22 Dec
2020

Three life sciences trade secrets and data strategy lessons

Recent technological and legal developments have increased the need for pharma and biotech companies to integrate clear data and trade secrets strategies into their broader IP approach.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth